Analysis of Organic Light Emitting Diode Materials by UltraPerformance Convergence Chromatography Coupled with Mass Spectrometry (UPC 2 /MS)

Similar documents
Streamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System

Routine MS Detection for USP Chromatographic Methods

UPC 2 Strategy for Scaling from Analytical to Preparative SFC Separations

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

USP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC

A Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone

Prep 150 LC System: Considerations for Analytical to Preparative Scaling

OVERVIEW INTRODUCTION. Michael O Leary, Jennifer Gough, Tanya Tollifson Waters Corporation, Milford, MA USA

UPC 2 Method Development for Achiral Impurity Analysis

Basic Principles for Purification Using Supercritical Fluid Chromatography

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

Effects of Aqueous Sample Content and Aqueous Co-Solvent Composition on UPC 2 Separation Performance

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

DEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR

[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.

Online Reaction Monitoring of In-Process Manufacturing Samples by UPLC

Implementation of Methods Translation between Liquid Chromatography Instrumentation

UPLC Intact MASS Analysis Application Kit

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

[ a ppl ic at ion no t e ]

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

C HA R AC T E RIZ AT IO N O F INK J E T P RINT E R C A RT RIDG E INK S USING A CHEMOMETRIC APPROACH

Peptide Isolation Using the Prep 150 LC System

Traditional Herbal Medicine Structural Elucidation using SYNAPT HDMS

Quantitation of High Resolution MS Data Using UNIFI: Acquiring and Processing Full Scan or Tof-MRM (Targeted HRMS) Datasets for Quantitative Assays

Solvent Flexibility for Size-Based Polymer Analysis Using the Advanced Polymer Chromatography (APC) System

Electron Transfer Dissociation of N-linked Glycopeptides from a Recombinant mab Using SYNAPT G2-S HDMS

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Enantiomeric and Diastereomeric Separations of Pyrethroids Using UPC 2

Expediting Achiral SFC Method Development Using a Multi-Channel SFC System with MS Detection

Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

Use of High Speed/High Resolution Size-Based Chromatographic Separation of Polymeric Mixtures with Offline Infrared Detection

Rapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies

Successfully Scaling and Transferring HPLC and UPLC Methods

Introduction. Chapter 1. Learning Objectives

Live Webinar : How to be more Successful with your ACQUITY QDa Detector?

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Identification of Human Hemoglobin Protein Variants Using Electrospray Ionization-Electron Transfer Dissociation Mass Spectrometry

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

PosterREPRINT COMPARISON OF PEAK PARKING VERSUS AUTOMATED FRACTION ANALYSIS OF A COMPLEX PROTEIN MIXTURE. Introduction

Application Note. Author. Abstract. Xinlei Yang Agilent Technologies Co. Ltd Shanghai, China

Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents

Determination of 15 phthalate esters by ultra performance convergence chromatography

viridis Columns Bringing a New Dimension to SFC Combining state-of-the-art media manufacturing with industry leading column technology, Viridis

LC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Lirui Qiao, 1 Rob Lewis, 2 Alex Hooper, 2 James Morphet, 2 Xiaojie Tan, 1 Kate Yu 3

Analysis of Trace (mg/kg) Thiophene in Benzene Using Two-Dimensional Gas Chromatography and Flame Ionization Detection Application

Analysis of Synthetic Cannabinoids and Metabolites: Adding New Compounds to an Existing LC-MS/MS Method

Analysis of Polyphenols in Saffron Petal Extracts with UHPLC/UV/MS

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

LC Technical Information

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

Fast methods for the determination of ibuprofen in drug products

Varian Galaxie Chromatography Data System for Preparative HPLC

APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEY WORDS. Simultaneous high-throughput screening of melamine (MEL) and cyanuric acid (CYA).

Multi-Channel SFC System for Fast Chiral Method Development and Optimization

Assay Robustness Improvement for Drug Urinalysis Using FAIMS and H-SRM on a Triple- Quadrupole Mass Spectrometer

Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA USA APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS

Q-TOF PREMIER DYNAMIC RANGE ENHANCEMENT AND ACCURATE MASS MEASUREMENT PERFORMANCE

High Throughpu[ Separations and Structural Information Achieved with Automated LC/MS. Michael P. Balogh, Matthew J. Dilts Waters Chromatography

Luna 2.5 µm C18(2)-HST. Advantages of 2.5 µm for increasing the speed of analysis while maintaining high efficiency

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

Definitive EtG/EtS LC-MS/MS Analysis:

Fast and Reliable Method for the Analysis of Methylmalonic Acid from Human Plasma

The Analysis of Organophosphate Pesticides by LC/MS Application

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Using High Speed/High Resolution Size Exclusion Chromatography Separation of Polymeric Materials with Light Scattering Detection

Agilent 1200 Infinity Series HDR DAD Impurity Analyzer System for the Quantification of Trace Level of Genotoxic Impurity

Integrated approach to HPLC method development: Using all the tools in the chromatographer s toolbox

High-Resolution Sampling 2D-LC for Pharmaceutical Impurity Analysis

Extraction of Methylmalonic Acid from Serum Using ISOLUTE. SAX Prior to LC-MS/MS Analysis

Bioanalytical Chem: 4590: LC-MSMS of analgesics LC-MS Experiment Liquid Chromatography Mass Spectrometry (LC/MS)

LC-MS/MS Method for the Determination of Diclofenac in Human Plasma

Tomorrow s quantitation with the TSQ Fortis mass spectrometer: quantitation of phenylephrine hydrochloride for QA/QC laboratories

Selecting Detectors for Compounds with No Optical Absorbance

High Performance Liquid Chromatography. Table 1: Allowed HPLC Adjustment of USP <621> and EP <2.2.46>

Application Note. Author. Abstract. Pharmaceutical QA/QC. Siji Joseph Agilent Technologies, Inc. Bangalore, India

Application Note. Gas Chromatography/Mass Spectrometry/Food Safety. Abstract. Authors

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

Assay Transfer from HPLC to UPLC for Higher Analysis Throughput

Confirmation of In Vitro Nefazodone Metabolites using the Superior Fragmentation of the QTRAP 5500 LC/MS/MS System

Simultaneous Determination of Paraquat and Diquat in Environmental Water Samples by HPLC-MS/MS

Certified Reference Material - Certificate of Analysis

The Low-Temperature Evaporative Light-Scattering Detector (LT-ELSD)

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Nexera UC Unified Chromatography

Performance evaluation of the Agilent 1290 Infinity 2D-LC Solution for comprehensive two-dimensional liquid chromatography

A Case of Pesticide Poisoning: The Use of a Broad-Scope Tof Screening Approach in Wildlife Protection

Dilution(*) Chromatography

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Application Note. Authors. Abstract. Energy & Chemicals, Biofuels & Alternative Energy

Luminescence transitions. Fluorescence spectroscopy

Technical Note. Introduction

Sensitive HILIC UHPLC-UV determination of steviol glycoside natural sweeteners

Transcription:

Analysis of Organic Light Emitting Diode Materials by UltraPerformance Convergence Chromatography Coupled with Mass Spectrometry (UPC 2 /MS) Michael D. Jones, Andrew Aubin, Peter J. Lee, and Tim Jenkins Waters Corporation, Milford, MA, USA A P P L I C AT IO B E E I T S Provides an approach to improved profiling of material purity 10X reduction in run time compared to previously published liquid chromatography techniques Significant cost reduction in mobile phase consumption and waste Approximately $1.91 for HPLC vs. $5 for UPC 2 Compatibility with normal phase diluents and extraction solvents associated with organic light emitting diode (OLED) analysis WAT E R S SO LU T IOS Waters ACQUITY UPC 2TM System ACQUITY UPC 2 Column Kit ACQUITY UPC 2 PDA Detector ACQUITY SQD Empower 3 CDS Software K E Y W O R D S ACQUITY UPC 2, supercritical fluid chromatography, fine chemical purity, patent protection, stability indicating methods, degradation profiling, PhOLED, OLED, (ppy) 3, impurities, phosphorescent emitter IT RO DU C T IO Organic light emitting diodes (OLEDs) are thin films that exhibit electroluminescence when an electric current is applied. They are used in a variety of everyday electronics such as televisions, mobile phones, computer monitors, watches, and display screens. The continued development and commercialization of OLEDs is of major interest to companies developing next-generation display technology and their suppliers. The raw materials used to construct OLED-based devices require high purity to extend the life of the luminescence and quality of the final product, specifically blue phosphorescent emitters. There is much intellectual property associated with OLED materials, so manufacturing a high quality OLED raw material can also be highly lucrative. Intellectual property is a strong driver for the OLED chemical materials business, which limits commoditization and drives high manufacturing costs for OLED-based devices. Market analysis reports point to OLEDs as a key niche market over the next five years, predicted to grow to a $5 billion market by 2016. 1 Typically, OLED materials are analyzed by various microscopy techniques. Interestingly, a limited amount of LC-based methods have been cited in publications analyzing the stability of phosphorescent emitters used in OLED devices. 2,3,4 Many of the published methods require an analysis time greater than 30 minutes. In this application note, a rapid and selective method was developed utilizing UltraPerformance Convergence Chromatography (UPC 2TM ) coupled with photodiode array detection and mass spectrometry to analyze the purity of an iridium complex dye, (ppy) 3, shown in igure 1. (ppy) 3 is a phosphorescent emitter material that is important for providing blue electroluminescence longevity for use in OLED devices. The method specificity was also evaluated in the presence of additional materials used in the construction of OLED devices. The developed UPC 2 method utilizes supercritical fluid chromatography (SC) carbon dioxide as the primary mobile phase, and methanol as a modifier acting as the strong solvent to elute the planar organo-metallic based constituents of interest. 1

E X P E R IM E TA L Sample Description Stock standards were prepared by diluting (ppy) 3 reference material in tetrahydrofuran to a concentration of approximately 1.0 mg/ml. Working standards were prepared by dilution of the (ppy) 3 stock standard with tetrahydrofuran to a concentration of 0.1 mg/ml. igure 1. The chemical structure of iridium complex Tris[2-(2,4-difluorophenyl)pyridine] iridium(iii), referred to as (ppy) 3. Method Conditions System: Waters ACQUITY UPC 2 Column: ACQUITY UPC 2 BEH 2-EP 3.0 x 100 mm, 1.7 µm Mobile phase A: CO 2 Mobile phase B: 2 g/l Ammonium formate in methanol Wash solvents: 70:30 Methanol/isopropanol Separation mode: Gradient: 10% to 25% B over 5 minutes; hold at 25% for 1 minute low rate: 2.0 ml/min CCM back pressure: 1885 psi Column temp.: 60 C Sample temp.: Ambient Injection volume: 2.0 µl Run time: 5.0 minutes Detection: ACQUITY UPC 2 PDA 3D Channel: 200 to 410 ; 20 Hz 2D Channel: 258 @ 4.8 resolution (Compensated 500 to 600 ) Mass spectrometer: ACQUITY SQD MS settings: 200 to 1200 Da; 10,000 Da/sec; ES Poseg Make-up flow: one Data management: Empower 3 CDS Software R E SU LT S A D D IS C U S S IO Method development Typical SC system configurations utilize a secondary pump to provide post column addition of proton-rich solvent, such as formic acid, to improve the ionization efficiency for MS analysis. The lack of ionization effectiveness of legacy SC configurations can be attributed to the high flow of high-percentage liquid CO 2 that lacks the protons required for ionization. The need for make-up flow was evaluated for use with UPC 2. The ACQUITY UPC 2 System configuration and methodology used for this analysis did not require a secondary pump for make-up flow to increase ionization. The flow to the mass spectrometer was split post-uv detection with an Upchurch zero volume PEEK tee. However, it was determined that using 30 cm of 025-inch I.D. PEEK tubing to the inlet of the MS probe provided enough back pressure after the split to maintain a supercritical CO 2 phase state. A method development scheme was initially designed to investigate three ACQUITY UPC 2 Columns providing differences in chromatographic selectivity. The columns utilized were UPC 2 BEH, UPC 2 BEH 2-EthylPyridine (2-EP), and UPC 2 CSH luoro-phenyl stationary phases, specifically designed for use with the UPC 2 instrumentation. Injections of the (ppy) 3 degraded sample were performed using a rapid 5-minute gradient screening method. Based on this method development scheme and system configuration, it was observed that the ACQUITY UPC 2 BEH 2-EP stationary phase provided the most optimal selectivity potential and best peak shape attributes to separate seven unknown impurities, as shown in igures 2 and 3. The spectra inset in igures 2 and 3 were used to determine relationship to the (ppy) 3 phosphorescent emitter. The MS data provided added sensitivity to detect trace-level impurities such as the smaller peaks detected between 1 and 2 minutes, shown in igure 3. By detecting these trace impurities by MS, the spectral information facilitates the determination of origin or possible relationship to the main species of interest. UPC 2 Analysis of (ppy) 3 2

UV 258 1.019 Peak 1 258.4 0.12 72 225.4 (ppy) 3 9 1.019 54 6 3 0 36 18 373.4 220 260 300 340 380 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 Minutes igure 2. UV 258 chromatogram (compensated 500 to 600 ) of (ppy) 3 and impurity peaks found in a degraded sample preparation. The integrated peak was determined as the (ppy) 3 analyte. The inset figure is the UV spectal profile of (ppy) 3 with an observed λ max of 258.4. 1.004 Peak 1 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune MS ES+ 2.8x10 7 763.92 9.0x10 7 (ppy) 3 1.003 2.1x10 7 7.2x10 7 761.95 1.4x10 7 5.4x10 7 7.0x10 6 744.80 748.60 752.40 756.20 760 763.80 767.60 771.40 775.20 779.00 3.6x10 7 1.8x10 7 0 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 Minutes igure 3. MS ES+ total ion chromatogram (TIC) of (ppy) 3 and impurity peaks found in a degraded sample preparation. The integrated peak was determined as the (ppy) 3 analyte. The adjacent figure is the MS spectral isotopic profile of (ppy) 3 with an observed base peak of 763.9 Da. Impurity Identification The peaks found in the UV and the MS data were integrated with spectral information extracted from the 3D data channels in Empower 3 CDS Software. The software provided the ability to extract MS spectra from UV peaks of interest within a single window for efficient data review. A total of seven impurity peaks were found after subtraction of the blank injection peaks. Retention time, UV spectra, and MS spectra are displayed in Table 1. Three of the seven impurities ( 1.360 min, 1.463 min, and 1.619 min) were observed to have similar UV spectral profiles to that of the (ppy) 3 phosphorescent emitter. The MS spectral analysis of the seven peaks revealed a distinct relationship to the (ppy) 3 phosphorescent emitter. The (ppy) 3 MS spectra have a unique isotopic ratio, as seen in the spectra found in igure 3. All seven impurity peaks possessed isotopic ion ratios similar to the (ppy) 3 phosphorescent emitter. Electrospray negative ion results were observed for three of the four later-eluting peaks. The negative ion information will help further investigations focused on impurity characterization by accurate mass measurements. UPC 2 Analysis of (ppy) 3 3

72 54 36 18 0120 0096 0072 0048 0024 0125 0100 0075 0050 0025 0100 0075 0050 0025 0000 52 39 26 13 1.019 Peak 1 1.360 Peak 2 213.7 221.9 227.8239.5 262.0 317.8 322.5 330.9 336.8 353.0360.2 367.4 381.8386.6 392.6 220 240 260 280 300 320 340 360 380 400 1.463 Peak 3 213.7 225.4 228.9 232.5 260.8 301.1 322.5 377.0 396.2 385.4 220 240 260 280 300 320 340 360 380 400 1.619 Peak 4 216.0 230.1233.6 241.9 258.4 220 240 260 280 300 320 340 360 380 400 260.8 292.8 315.4 322.5 330.9 336.8348.2 360.2 375.8 393.8398.6 220 240 260 280 300 320 340 360 380 400 2.746 Peak 6 255 236.0 204 153 102 051 3.622 Peak 7 237.2 030 212.5 024 018 012 006 4.124 Peak 8 0375 238.4 212.5 221.9 0300 0225 0150 0075 1.935 Peak 5 234.8 270.3 273.8 220 240 260 280 300 320 340 360 380 400 275.0 264.3 272.6 373.4 368.6 341.3 354.2 383.0 220 240 260 280 300 320 340 360 380 400 314.2 320.1323.7 332.1345.9 363.8 367.4 379.4383.0386.6 220 240 260 280 300 320 340 360 380 400 343.6 345.9 371.0 380.6 220 240 260 280 300 320 340 360 380 400 2.8x10 7 2.1x10 7 1.4x10 7 7.0x10 6 3.6x10 6 2.7x10 6 1.8x10 6 9.0x10 5 4.8x10 6 3.6x10 6 2.4x10 6 1.2x10 6 4x10 6 3x10 6 2x10 6 1x10 6 2.8x10 7 2.1x10 7 1.4x10 7 7.0x10 6 2.4x10 7 1.8x10 7 1.2x10 7 6.0x10 6 0 1.004 Peak 1 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 763.92 761.95 1.345 Peak 2 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 745.90 743.93 734.40 737.10 739.80 742.50 745.20 747.90 750.60 753.30 756.00 758.70 1.446 Peak 3 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 745.91 743.97 738.00 740 742.00 744.00 746.00 748.00 750 752.00 754.00 1.601 Peak 4 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 745.90 743.90 746.97 765.01 759.60 760.80 762.00 763.20 764.40 765.60 766.80 768.00 769.20 739.20 741.30 743.40 745.50 747.60 749.70 751.80 753.90 756.00 1.922 Peak 6 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 763.93 761.97 765.08 757.80 759.60 761.40 763.20 765.00 766.80 768.60 770.40 772.20 2.731 Peak 7 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 745.95 743.96 747.05 738.00 740 742.00 744.00 746.00 748.00 750 752.00 754.00 756.00 6.4x10 6 4.8x10 6 3.2x10 6 1.6x10 6 4.8x10 6 3.6x10 6 2.4x10 6 1.2x10 6 3.605 Peak 8 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 727.94 725.97 729.01 722.40 723.80 725.20 726.60 728.00 729.40 730.80 732.20 733.60 735.00 4.101 Peak 9 - SQ 1: MS Scan 1: 300-1000 ES+, Centroid, CV=Tune 805.99 804.01 806.96 802.80 803.70 804.60 805.50 806.40 807.30 808.20 809.10 810 1.00x10 7 7.50x10 6 5.00x10 6 2.50x10 6 1.920 Peak 1 - SQ 2: MS Scan 2: 300-1000 ES-, Centroid, CV=Tune 808.0 806.0 0 798.60 800.80 803.00 805.20 807.40 809.60 811.80 814.00 816.20 818.40 809.0 2.730 Peak 2 - SQ 2: MS Scan 2: 300-1000 ES-, Centroid, CV=Tune 789.9 2.4x10 6 1.8x10 6 1.2x10 6 6.0x10 5 787.9 785.40 786.50 787.60 788.70 789.80 790.90 792.00 793.10 794.20 795.30 790.9 4.103 Peak 3 - SQ 2: MS Scan 2: 300-1000 ES-, Centroid, CV=Tune 85 2.0x10 6 1.5x10 6 1.0x10 6 5.0x10 5 848.0 849.0 846.00 847.00 848.00 849.00 850 851.00 852.00 853.00 854.00 855.00 851.0 Unknown impurity characterization using nominal mass measurements is typically undesirable; however, the impurities observed during this experiment resemble the same isotopic patterns as the parent (ppy) 3 compound. Based on the MS results, it is hypothesized that the unknown peak at retention time 1.94 minutes is an (ppy) 3 isomer. The unknown peaks at retention times 1.330 min, 1.463 min, 1.619 min, and 2.75 min each represents a reduction of a fluorine atom from one of the fluoro-phenyl rings. The unknown peak at 3.622 min represents a reduction of two fluorine atoms from one of the fluoro-phenyl rings. The peak eluting at 4.12 min requires further investigation by MS/MS and accurate mass to better characterize a proposed structure, as shown in igure 4. Retention Time UV Spectra MS ES+ Spectra MS ES- Spectra (ppy) 3 1.11 min ES+ ES- 258.4 763.9 /A 1.36 min /A ES+ ES- 262.0 745.9 /A /A 1.46 min ES+ ES- 260.8 745.9 /A 348.2 351.8 355.4362.6 /A 1.62 min ES+ ES- 260.8 763.9 /A /A 1.94 min ES+ ES- 234.8 763.9 808.0 2.75 min ES+ ES- 236.0 746.0 789.9 371.0 384.2 3.62 min ES+ ES- 237.2 727.9 /A /A 4.12 min ES+ ES- 238.4 806.0 85 Table 1. Table of retention times, UV observed spectral profile, MS ES+ observed spectral profile, MS ES- observed spectral profile (if present). The MS spectral profiles verify similar isotopic patterns. Combined with the UV spectra, the unknown peaks were determined to be related to (ppy) 3. UPC 2 Analysis of (ppy) 3 4

(ppy ) 3 0.12 9 1.019 (ppy ) 3 Isomer (ppy ) 3 - (ppy ) 3-2 6 3 (ppy ) 3 Isomers 1.935 2.746 Related unknown 0 1.360 1.463 1.619 3.622 4.124 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 Mi Minutes t igure 4. Proposed structure assigents for the unknown impurities found in the (ppy) 3 phosphorescent emitter sample. Investigation of Specificity The method was investigated in terms of specificity using a mixture of other main ingredients used in the construction of OLED devices. The constituents within the mixture represent the phosphorescent emitter [(ppy) 3 ], the hole transport material (α-hp), the host material (TCTA), and the hole blocking material/ electron transport material Alq 3. The mixture was injected, and the assay method was determined to be specific to analyze all three doped compounds without interference with the [ppy] 3 phosphorescent emmitter. System precision was determined over n=5 injections to assess method reproducibility, displayed in igure 5. 0.100 75 (ppy) 3 Area = 0.4% Rt = 0.1% 1.009 α-hp Area = 0.4% Rt = 0.1% 1.421 TCTA Area = 1.1% Rt = 0.1% Alq 3 Area = 1.1% Rt = 0.1% 1.920 2.471 50 2.028 25 00 0 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 Minutes igure 5. Method tested for specificity and system precision. Overlay of a mixture of commonly used components in OLED production (n=5). %RSD of retention time and area are reported above each major compound in the mixture. The additional impurity peaks are those impurities related to (ppy) 3. UPC 2 Analysis of (ppy) 3 5

C O C LUSIOS A rapid 5-minute UPC 2 /MS method was developed to analyze (ppy) 3 phosphorescent emitter purity, and an approach to monitor long-term stability. The MS data provided by the ACQUITY SQD facilitated characterization of three of the unknown impurity peaks. The UPC 2 approach resulted in up to 10X improvements in run time, solvent consumption, and considerably reduced amounts of solvent waste when compared with previously reported LC/MS techniques that used 100% organic solvents during the analysis. The highly selective and uatched specificity of this UPC 2 approach will help chemical material manufacturers better understand and control the performance of these unstable blue phospho-organic light emitting diodes, ultimately leading to better quality OLED-based products and a means to improve protection of intellectual property. References 1. Bcc Research Market Report SMC069B, Organic Light Emitting Diodes (OLEDs): Technologies and Global Markets July 2011 2. Sivasubramaniam et al, Investigation of pic in PhOLEDs via LC/MS Technique, Cent. Eur. J. Chemistry, 7(4), (2009), 836-845 3. Baranoff et al, Sublimation ot an Innocent Technique: A Case of Bis-Cyclometalated idium Emoitter for OLED, Inorg. Chem, 47, (2008), 6575-6577 4. Kondakov, D., Lenhart, W., and ichols, W., Operational degradation of organic light-emitting diodes: Mechanism and identification of chemical products, J. Appl. Physics, 101, 024512, (2007) Waters and ACQUITY are registered trademarks of Waters Corporation. UltraPerformance Convergence Chromatography, UPC 2, ACQUITY UPC 2, Empower, and The Science of What s Possible are trademarks of Waters Corporation. All other trademarks are the property of their respective owners. 2012 Waters Corporation. Produced in the U.S.A. April 2012 720004305E AG-PD Waters Corporation 34 Maple Street Milford, MA 01757 U.S.A. T: 1 508 478 2000 : 1 508 872 1990 www.waters.com